FindMyKOL
Clinical trialNCT01360606CompletedInterventional

Stereotactic Body Radiation Therapy (SBRT) for Liver Mets

SponsorSusannah EllsworthEnrollment9Liver Metastases
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase I dose escalation study. Dose escalation will be via the traditional "up and down" scheme. SBRT: Patients will receive one of the following radiation regimens: * 50 Gy in 5 fractions (10 Gy/fx) delivered over a 2-week period. * 60 Gy in 5 fractions (12 Gy/fx) delivered over a 2-week period. * 75 Gy in 5 fractions (15 Gy/fx) delivered over a 2-week period.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Upmc Hillman Cancer Center - Radiation Oncology

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Mar 2012
Primary completion
25 Jul 2018
Completion
4 Feb 2021
Last update posted
10 Oct 2024
Registered enrollment
9
Registry id
NCT01360606

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.